Rare diseases
Investigational molecules
Locations
Back to Italy1 231 clinical trials in Pozzuoli, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases
ItalyStudy on the Safety and Effectiveness of Acasunlimab and Pembrolizumab for Patients with Recurrent Non-Small Cell Lung Cancer
ItalyStudy of Atezolizumab, Carboplatin, and Etoposide with or Without Tiragolumab for Patients with Untreated Extensive-Stage Small Cell Lung Cancer
ItalyStudy on Pembrolizumab for Patients with Resectable Metastases from Kidney Cancer
ItalyStudy of Efgartigimod for Adults with Thyroid Eye Disease
ItalyStudy of N-Acetyl-GED-0507-34-LEVO gel 5% applied daily for treating acne vulgaris
ItalyLong-term Study of Sotatercept for Adults with Pulmonary Arterial Hypertension (PAH)
ItalyStudy on the Effectiveness and Safety of Golcadomide and Rituximab for Patients with Newly Diagnosed Advanced Follicular Lymphoma
ItalyStudy on the Effectiveness and Safety of Osimertinib for Patients with Early-Stage Non-Small Cell Lung Cancer After Tumor Removal
ItalyStudy of Avalotcagene Ontaparvovec for Patients Aged 12 and Older with Late-onset Ornithine Transcarbamylase Deficiency
ItalyStudy on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma
ItalyStudy on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trial activity in Località la Schiana, Pozzuoli is strongly focused on cancer research, with studies examining how to improve treatment options for several advanced solid tumors. The main goal is to test new therapeutic strategies and refine existing combinations for better disease control and patient outcomes.
These studies are exploring more effective ways to slow progression, overcome treatment resistance, and improve survival in patients with advanced neoplasms.
Several trials in this site concentrate on digestive system cancers, especially advanced colorectal cancer. Research is centered on evaluating treatment effectiveness and finding better options for patients whose disease has already progressed or carries specific genetic changes.
Across these studies, the focus is on improving tumor response, extending disease control, and identifying which patients may benefit most from targeted treatment approaches.
This research landscape also includes therapeutic techniques aimed at improving how treatments are delivered and how response is monitored. The trials are not only testing active therapies, but also looking for better ways to understand resistance, safety, and treatment benefit in real-world patients.
In this part of the research portfolio, investigators in Pozzuoli are helping shape more precise and patient-centered cancer care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
